CSF2 and type 1 diabetes mellitus: We used this assay to profile epigenetic modification and transcription potential in isolated monocytes from 10 T1D and 4 healthy, non-autoimmune control subjects without stimulation or after ex vivo stimulation with GM-CSF, and IL-4 (Figures 4&5).